Literature DB >> 34048017

Sepsis Biomarkers.

Yachana Kataria1, Daniel Remick2.   

Abstract

Biomarkers have been used in sepsis to assist with the diagnosis of disease as well as determining the severity of disease, that is, prognosis. These biomarkers are based on the presence of discrete molecules within the blood. Unfortunately, in 2020, a single biomarker does not have sufficient sensitivity and specificity to definitively rule in or rule out sepsis. Biomarkers have shown better performance in animal models of disease.

Entities:  

Keywords:  Antibiotics; C-reactive protein; IL-6; Procalcitonin; Sepsis

Year:  2021        PMID： 34048017     DOI： 10.1007/978-1-0716-1488-4_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  72 in total

Review 1.  Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

Authors:  Elizabeth K Stevenson; Amanda R Rubenstein; Gregory T Radin; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

2.  [Effect of monomycin and neomycin on secretion and chemical composition of gastric juice in dogs at different conditions of central nervous system].

Authors:  E A Govorovich; L V Elagina
Journal:  Antibiotiki       Date:  1966-07

Review 3.  Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.

Authors:  T Hirano
Journal:  Int J Cell Cloning       Date:  1991-05

Review 4.  Sepsis biomarkers.

Authors:  Miroslav Prucha; Geoff Bellingan; Roman Zazula
Journal:  Clin Chim Acta       Date:  2014-11-18       Impact factor: 3.786

5.  No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.

Authors:  Dirk Sibbing; Werner Koch; Steffen Massberg; Robert A Byrne; Julinda Mehilli; Stefanie Schulz; Katharina Mayer; Isabell Bernlochner; Albert Schömig; Adnan Kastrati
Journal:  Eur Heart J       Date:  2011-04-28       Impact factor: 29.983

Review 6.  The IL-1 family: regulators of immunity.

Authors:  John E Sims; Dirk E Smith
Journal:  Nat Rev Immunol       Date:  2010-01-18       Impact factor: 53.106

7.  Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014.

Authors:  Chanu Rhee; Raymund Dantes; Lauren Epstein; David J Murphy; Christopher W Seymour; Theodore J Iwashyna; Sameer S Kadri; Derek C Angus; Robert L Danner; Anthony E Fiore; John A Jernigan; Greg S Martin; Edward Septimus; David K Warren; Anita Karcz; Christina Chan; John T Menchaca; Rui Wang; Susan Gruber; Michael Klompas
Journal:  JAMA       Date:  2017-10-03       Impact factor: 56.272

Review 8.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

9.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations.

Authors:  Carolin Fleischmann; André Scherag; Neill K J Adhikari; Christiane S Hartog; Thomas Tsaganos; Peter Schlattmann; Derek C Angus; Konrad Reinhart
Journal:  Am J Respir Crit Care Med       Date:  2016-02-01       Impact factor: 21.405

10.  Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis.

Authors:  Julie A Stortz; Tyler J Murphy; Steven L Raymond; Juan C Mira; Ricardo Ungaro; Marvin L Dirain; Dina C Nacionales; Tyler J Loftus; Zhongkai Wang; Tezcan Ozrazgat-Baslanti; Gabriela L Ghita; Babette A Brumback; Alicia M Mohr; Azra Bihorac; Philip A Efron; Lyle L Moldawer; Frederick A Moore; Scott C Brakenridge
Journal:  Shock       Date:  2018-03       Impact factor: 3.454
View more
  1 in total

1.  The Levels of Oxidized Phospholipids in High-Density Lipoprotein During the Course of Sepsis and Their Prognostic Value.

Authors:  Zhaohong Li; Zengtao Luo; Xiaoqian Shi; Baosen Pang; Yingmin Ma; Jiawei Jin
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.